The protective effect of fibroblast growth factor‐21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function

Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality. Fibroblast growth factor 21 (FGF21) is a well‐established cardioprotective factor. We aimed to study the role of FGF21 in experimentally induced...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pathology Vol. 253; no. 2; pp. 198 - 208
Main Authors Ferrer‐Curriu, Gemma, Guitart‐Mampel, Mariona, Rupérez, Celia, Zamora, Monica, Crispi, Fatima, Villarroya, Francesc, Fernández‐Solà, Joaquim, Garrabou, Gloria, Planavila, Anna
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.02.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality. Fibroblast growth factor 21 (FGF21) is a well‐established cardioprotective factor. We aimed to study the role of FGF21 in experimentally induced models and clinical affected patients with cardiac damage due to chronic alcohol consumption. We found that circulating FGF21 levels and cardiac FGF21 and β‐klotho protein levels were increased in subjects with chronic alcohol consumption. As an experimental model of ACM, we fed wild‐type and Fgf21 knockout (Fgf21−/−) mice with a 4% alcohol liquid diet for 4 and 12 weeks. FGF21 circulating levels and FGF21 expression in the myocardium were also increased in wild‐type mice after chronic alcohol intake. Fgf21−/− mice develop a higher degree of cardiac hypertrophy, fibrosis, and cardiac dysfunction after chronic alcohol consumption than wild‐type mice. Moreover, the myocardium of Fgf21−/− mice showed signs of metabolic deregulation, oxidative stress, and mitochondrial dysfunction after alcohol intake. Finally, human cardiac biopsies from patients with chronic alcohol consumption developing ACM presented a higher degree of oxidative stress which positively correlated with the FGF21 protein levels in the myocardium. We conclude that plasma levels and cardiac myocyte FGF21 expression were induced in response to chronic alcohol consumption. The lack of FGF21 aggravated cardiac damage produced by ACM, in association with enhanced mitochondrial and oxidative stress, thus pointing to FGF21 as a protective agent against development of alcohol‐induced cardiomyopathy. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
AbstractList Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality. Fibroblast growth factor 21 (FGF21) is a well‐established cardioprotective factor. We aimed to study the role of FGF21 in experimentally induced models and clinical affected patients with cardiac damage due to chronic alcohol consumption. We found that circulating FGF21 levels and cardiac FGF21 and β‐klotho protein levels were increased in subjects with chronic alcohol consumption. As an experimental model of ACM, we fed wild‐type and Fgf21 knockout ( Fgf21 −/− ) mice with a 4% alcohol liquid diet for 4 and 12 weeks. FGF21 circulating levels and FGF21 expression in the myocardium were also increased in wild‐type mice after chronic alcohol intake. Fgf21 −/− mice develop a higher degree of cardiac hypertrophy, fibrosis, and cardiac dysfunction after chronic alcohol consumption than wild‐type mice. Moreover, the myocardium of Fgf21 −/− mice showed signs of metabolic deregulation, oxidative stress, and mitochondrial dysfunction after alcohol intake. Finally, human cardiac biopsies from patients with chronic alcohol consumption developing ACM presented a higher degree of oxidative stress which positively correlated with the FGF21 protein levels in the myocardium. We conclude that plasma levels and cardiac myocyte FGF21 expression were induced in response to chronic alcohol consumption. The lack of FGF21 aggravated cardiac damage produced by ACM, in association with enhanced mitochondrial and oxidative stress, thus pointing to FGF21 as a protective agent against development of alcohol‐induced cardiomyopathy. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality. Fibroblast growth factor 21 (FGF21) is a well‐established cardioprotective factor. We aimed to study the role of FGF21 in experimentally induced models and clinical affected patients with cardiac damage due to chronic alcohol consumption. We found that circulating FGF21 levels and cardiac FGF21 and β‐klotho protein levels were increased in subjects with chronic alcohol consumption. As an experimental model of ACM, we fed wild‐type and Fgf21 knockout (Fgf21−/−) mice with a 4% alcohol liquid diet for 4 and 12 weeks. FGF21 circulating levels and FGF21 expression in the myocardium were also increased in wild‐type mice after chronic alcohol intake. Fgf21−/− mice develop a higher degree of cardiac hypertrophy, fibrosis, and cardiac dysfunction after chronic alcohol consumption than wild‐type mice. Moreover, the myocardium of Fgf21−/− mice showed signs of metabolic deregulation, oxidative stress, and mitochondrial dysfunction after alcohol intake. Finally, human cardiac biopsies from patients with chronic alcohol consumption developing ACM presented a higher degree of oxidative stress which positively correlated with the FGF21 protein levels in the myocardium. We conclude that plasma levels and cardiac myocyte FGF21 expression were induced in response to chronic alcohol consumption. The lack of FGF21 aggravated cardiac damage produced by ACM, in association with enhanced mitochondrial and oxidative stress, thus pointing to FGF21 as a protective agent against development of alcohol‐induced cardiomyopathy. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality. Fibroblast growth factor 21 (FGF21) is a well-established cardioprotective factor. We aimed to study the role of FGF21 in experimentally induced models and clinical affected patients with cardiac damage due to chronic alcohol consumption. We found that circulating FGF21 levels and cardiac FGF21 and β-klotho protein levels were increased in subjects with chronic alcohol consumption. As an experimental model of ACM, we fed wild-type and Fgf21 knockout (Fgf21 ) mice with a 4% alcohol liquid diet for 4 and 12 weeks. FGF21 circulating levels and FGF21 expression in the myocardium were also increased in wild-type mice after chronic alcohol intake. Fgf21 mice develop a higher degree of cardiac hypertrophy, fibrosis, and cardiac dysfunction after chronic alcohol consumption than wild-type mice. Moreover, the myocardium of Fgf21 mice showed signs of metabolic deregulation, oxidative stress, and mitochondrial dysfunction after alcohol intake. Finally, human cardiac biopsies from patients with chronic alcohol consumption developing ACM presented a higher degree of oxidative stress which positively correlated with the FGF21 protein levels in the myocardium. We conclude that plasma levels and cardiac myocyte FGF21 expression were induced in response to chronic alcohol consumption. The lack of FGF21 aggravated cardiac damage produced by ACM, in association with enhanced mitochondrial and oxidative stress, thus pointing to FGF21 as a protective agent against development of alcohol-induced cardiomyopathy. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality. Fibroblast growth factor 21 (FGF21) is a well-established cardioprotective factor. We aimed to study the role of FGF21 in experimentally induced models and clinical affected patients with cardiac damage due to chronic alcohol consumption. We found that circulating FGF21 levels and cardiac FGF21 and β-klotho protein levels were increased in subjects with chronic alcohol consumption. As an experimental model of ACM, we fed wild-type and Fgf21 knockout (Fgf21-/- ) mice with a 4% alcohol liquid diet for 4 and 12 weeks. FGF21 circulating levels and FGF21 expression in the myocardium were also increased in wild-type mice after chronic alcohol intake. Fgf21-/- mice develop a higher degree of cardiac hypertrophy, fibrosis, and cardiac dysfunction after chronic alcohol consumption than wild-type mice. Moreover, the myocardium of Fgf21-/- mice showed signs of metabolic deregulation, oxidative stress, and mitochondrial dysfunction after alcohol intake. Finally, human cardiac biopsies from patients with chronic alcohol consumption developing ACM presented a higher degree of oxidative stress which positively correlated with the FGF21 protein levels in the myocardium. We conclude that plasma levels and cardiac myocyte FGF21 expression were induced in response to chronic alcohol consumption. The lack of FGF21 aggravated cardiac damage produced by ACM, in association with enhanced mitochondrial and oxidative stress, thus pointing to FGF21 as a protective agent against development of alcohol-induced cardiomyopathy. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality. Fibroblast growth factor 21 (FGF21) is a well-established cardioprotective factor. We aimed to study the role of FGF21 in experimentally induced models and clinical affected patients with cardiac damage due to chronic alcohol consumption. We found that circulating FGF21 levels and cardiac FGF21 and β-klotho protein levels were increased in subjects with chronic alcohol consumption. As an experimental model of ACM, we fed wild-type and Fgf21 knockout (Fgf21-/- ) mice with a 4% alcohol liquid diet for 4 and 12 weeks. FGF21 circulating levels and FGF21 expression in the myocardium were also increased in wild-type mice after chronic alcohol intake. Fgf21-/- mice develop a higher degree of cardiac hypertrophy, fibrosis, and cardiac dysfunction after chronic alcohol consumption than wild-type mice. Moreover, the myocardium of Fgf21-/- mice showed signs of metabolic deregulation, oxidative stress, and mitochondrial dysfunction after alcohol intake. Finally, human cardiac biopsies from patients with chronic alcohol consumption developing ACM presented a higher degree of oxidative stress which positively correlated with the FGF21 protein levels in the myocardium. We conclude that plasma levels and cardiac myocyte FGF21 expression were induced in response to chronic alcohol consumption. The lack of FGF21 aggravated cardiac damage produced by ACM, in association with enhanced mitochondrial and oxidative stress, thus pointing to FGF21 as a protective agent against development of alcohol-induced cardiomyopathy. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Author Villarroya, Francesc
Ferrer‐Curriu, Gemma
Crispi, Fatima
Planavila, Anna
Zamora, Monica
Fernández‐Solà, Joaquim
Garrabou, Gloria
Guitart‐Mampel, Mariona
Rupérez, Celia
Author_xml – sequence: 1
  givenname: Gemma
  surname: Ferrer‐Curriu
  fullname: Ferrer‐Curriu, Gemma
  organization: CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN)
– sequence: 2
  givenname: Mariona
  surname: Guitart‐Mampel
  fullname: Guitart‐Mampel, Mariona
  organization: University of Barcelona, Internal Medicine Service – Hospital Clínic of Barcelona, Barcelona and CIBERER
– sequence: 3
  givenname: Celia
  surname: Rupérez
  fullname: Rupérez, Celia
  organization: CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN)
– sequence: 4
  givenname: Monica
  surname: Zamora
  fullname: Zamora, Monica
  organization: Institut Clinic de Ginecologia, Obstetricia i Neonatalogia, Institut d'Investigacions Biomediques August Pi i Sunyer, University of Barcelona
– sequence: 5
  givenname: Fatima
  surname: Crispi
  fullname: Crispi, Fatima
  organization: Institut Clinic de Ginecologia, Obstetricia i Neonatalogia, Institut d'Investigacions Biomediques August Pi i Sunyer, University of Barcelona
– sequence: 6
  givenname: Francesc
  surname: Villarroya
  fullname: Villarroya, Francesc
  organization: CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN)
– sequence: 7
  givenname: Joaquim
  surname: Fernández‐Solà
  fullname: Fernández‐Solà, Joaquim
  organization: CIBEROBN Fisiopatología de la Obesidad y la Nutrición, Instituto Carlos III
– sequence: 8
  givenname: Gloria
  surname: Garrabou
  fullname: Garrabou, Gloria
  email: garrabou@clinic.cat
  organization: University of Barcelona, Internal Medicine Service – Hospital Clínic of Barcelona, Barcelona and CIBERER
– sequence: 9
  givenname: Anna
  orcidid: 0000-0001-5474-4724
  surname: Planavila
  fullname: Planavila, Anna
  email: aplanavila@ub.edu
  organization: CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33125701$$D View this record in MEDLINE/PubMed
BookMark eNp90UFvFCEUB3Biauy2evALGBIv9jAtDAMs3prGWpMmeljPE2CgQ8PACkybvXnz6mf0k8i4rYcmeoLk_d7LP-8dgYMQgwHgNUanGKH2bCvLeEopJ8_ACiPBGrEW7ACsaq1tSIf5ITjK-RYhJASlL8AhIbilHOEV-LEZDdymWIwu7s5AY239wWihdSpF5WUu8CbF-zJCK3WJ6df3ny2GLkDpdRyjdxpqmQYXp11cguzeQwlT9GYxj5PDzR5JDSdXoh5jGJKTHto51HIML8FzK302rx7eY_D18sPm4qq5_vzx08X5daMJJaThRA3GUrbGHVMWIyaYGjiTbN0iboVppVScciaw1h2VRrGBK6Yw0xpbNHTkGLzbz63Jvs0ml35yWRvvZTBxzn3bUdZhxMVC3z6ht3FOoaarivMaYY1IVW8e1KwmM_Tb5CaZdv3jiis42QOdYs7J2L8Eo345X79srV_OV-3ZE6tdkct-SpLO_6_j3nmz-_fo_sv55upPx28g3a7Q
CitedBy_id crossref_primary_10_1016_j_isci_2024_110389
crossref_primary_10_1111_acer_15391
crossref_primary_10_1016_j_gendis_2023_05_019
crossref_primary_10_3389_fendo_2021_802541
crossref_primary_10_3389_fonc_2022_832804
crossref_primary_10_1002_ctm2_1806
crossref_primary_10_1111_jcmm_17318
crossref_primary_10_3389_fcvm_2022_962561
crossref_primary_10_3390_jcm11030580
crossref_primary_10_1002_path_5654
crossref_primary_10_3390_cells11162576
crossref_primary_10_1002_wsbm_1549
crossref_primary_10_1097_CM9_0000000000001890
crossref_primary_10_1016_j_ijbiomac_2024_136911
crossref_primary_10_1002_path_6193
crossref_primary_10_1155_2022_5042762
crossref_primary_10_3390_ijms222212341
crossref_primary_10_1016_j_intimp_2024_111925
crossref_primary_10_3389_fcvm_2021_720581
crossref_primary_10_1016_j_cellsig_2024_111379
crossref_primary_10_1016_j_cstres_2024_03_009
crossref_primary_10_1161_CIRCHEARTFAILURE_121_008910
crossref_primary_10_1186_s12985_024_02605_6
Cites_doi 10.2459/JCM.0b013e32833833a3
10.1371/journal.pone.0129791
10.1136/heartjnl-2017-312384
10.1016/j.ijcard.2018.02.109
10.1016/j.yjmcc.2010.03.017
10.1016/j.cmet.2013.08.014
10.3389/fendo.2015.00133
10.3389/fendo.2014.00107
10.3390/nu12020572
10.1038/ncomms3019
10.1016/j.cmet.2015.12.008
10.1002/hep.27060
10.1016/j.yjmcc.2008.02.276
10.1016/j.cmet.2014.02.004
10.1172/JCI31044
10.1042/CS20170271
10.1378/chest.121.5.1638
10.1212/WNL.0000000000003374
10.1093/cvr/cvu263
10.1016/j.bbalip.2004.11.004
10.1111/acer.12111
10.1002/path.5226
10.1016/j.yjmcc.2013.02.005
10.1161/CIRCULATIONAHA.108.845792
10.1016/j.jchf.2014.07.014
10.1016/j.molmet.2018.03.010
10.1016/j.cmet.2017.04.009
10.1186/s12933-015-0190-7
10.3390/ijms17101651
10.1016/0002-8703(93)90175-9
10.1097/HJH.0000000000000493
10.1152/ajpheart.00214.2016
10.1016/j.freeradbiomed.2010.07.020
10.1016/j.molmet.2017.08.004
10.1159/000486127
10.1038/srep31026
10.1073/pnas.1611243113
10.1136/heartjnl-2018-314443
10.1111/apha.12698
ContentType Journal Article
Copyright 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Copyright © 2021 Pathological Society of Great Britain and Ireland
Copyright_xml – notice: 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
– notice: Copyright © 2021 Pathological Society of Great Britain and Ireland
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1002/path.5573
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9896
EndPage 208
ExternalDocumentID 33125701
10_1002_path_5573
PATH5573
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Ministerio de Ciencia e Innovación
  funderid: RTI2018‐096137‐B‐I00; RYC‐2014‐16572; SAF2017‐85722‐R
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1KJ
1L6
1OB
1OC
1ZS
29L
31~
33P
3O-
3SF
3UE
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
GSXLS
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M68
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OHT
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
XPP
XV2
YQI
YQJ
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
7TO
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3533-73bdef568146bf10696bd76a68207f9e2aab757691cc45aeb6d7b6b16cc1f0d43
IEDL.DBID DR2
ISSN 0022-3417
1096-9896
IngestDate Fri Jul 11 16:04:25 EDT 2025
Fri Jul 25 12:17:06 EDT 2025
Thu Apr 03 07:03:11 EDT 2025
Thu Apr 24 22:50:58 EDT 2025
Tue Jul 01 04:21:19 EDT 2025
Wed Jan 22 16:32:03 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords alcohol
hypertrophy
mitochondria
alcoholic cardiomyopathy
fibrosis
heart
oxidative stress
FGF21
Language English
License 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3533-73bdef568146bf10696bd76a68207f9e2aab757691cc45aeb6d7b6b16cc1f0d43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5474-4724
PMID 33125701
PQID 2477814803
PQPubID 1006392
PageCount 11
ParticipantIDs proquest_miscellaneous_2456410794
proquest_journals_2477814803
pubmed_primary_33125701
crossref_primary_10_1002_path_5573
crossref_citationtrail_10_1002_path_5573
wiley_primary_10_1002_path_5573_PATH5573
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2021
2021-02-00
20210201
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: February 2021
PublicationDecade 2020
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
– name: Bognor Regis
PublicationTitle The Journal of pathology
PublicationTitleAlternate J Pathol
PublicationYear 2021
Publisher John Wiley & Sons, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Wiley Subscription Services, Inc
References 2010; 11
2017; 6
2015; 14
2015; 6
2013; 4
2015; 3
2018; 260
2017; 25
2018; 104
2015; 33
2015; 10
2019; 248
2020; 12
2015; 106
2017; 131
1993; 125
2016; 17
2014; 60
2013; 18
2016; 6
2010; 49
2013; 37
2013; 59
2014; 5
2007; 117
2014; 2
2018; 139
2002; 121
2016; 217
2016; 113
2016; 87
2016; 310
2008; 44
2014; 19
2018; 11
2005; 1687
2011; 123
2016; 23
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
Laurent D (e_1_2_7_35_1) 2014; 2
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
e_1_2_7_39_1
33630303 - J Pathol. 2021 Jul;254(3):213-215
References_xml – volume: 125:
  start-page: 808
  year: 1993
  end-page: 817
  article-title: Clinical and histologic features of alcohol drinkers with congestive heart failure
  publication-title: Am Heart J
– volume: 17:
  start-page: 1
  year: 2016
  end-page: 22
  article-title: New treatment strategies for alcohol‐induced heart damage
  publication-title: Int J Mol Sci
– volume: 131:
  start-page: 1877
  year: 2017
  end-page: 1893
  article-title: FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK‐paraoxonase 1 signaling axis in mice
  publication-title: Clin Sci (Lond)
– volume: 49:
  start-page: 322
  year: 2010
  end-page: 329
  article-title: Aldehyde dehydrogenase 2 knockout accentuates ethanol‐induced cardiac depression: role of protein phosphatases
  publication-title: J Mol Cell Cardiol
– volume: 87:
  start-page: 2290
  year: 2016
  end-page: 2299
  article-title: FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
  publication-title: Neurology
– volume: 104:
  start-page: 1663
  year: 2018
  end-page: 1669
  article-title: National, regional and global mortality due to alcoholic cardiomyopathy in 2015
  publication-title: Heart
– volume: 19:
  start-page: 458
  year: 2014
  end-page: 469
  article-title: Tissue‐specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart
  publication-title: Cell Metab
– volume: 44:
  start-page: 992
  year: 2008
  end-page: 1001
  article-title: Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion‐induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress
  publication-title: J Mol Cell Cardiol
– volume: 5:
  start-page: 107
  year: 2014
  article-title: FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases
  publication-title: Front Endocrinol (Lausanne)
– volume: 121:
  start-page: 1638
  year: 2002
  end-page: 1650
  article-title: Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology
  publication-title: Chest
– volume: 310:
  start-page: H1658
  year: 2016
  end-page: H1670
  article-title: Chronic plus binge ethanol feeding induces myocardial oxidative stress, mitochondrial and cardiovascular dysfunction, and steatosis
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 113:
  start-page: 14372
  year: 2016
  end-page: 14377
  article-title: is associated with alcohol drinking, and its gene product β‐Klotho is necessary for FGF21 regulation of alcohol preference
  publication-title: Proc Natl Acad Sci U S A
– volume: 6:
  start-page: 133
  year: 2015
  article-title: FGF21 and cardiac physiopathology
  publication-title: Front Endocrinol (Lausanne)
– volume: 106:
  start-page: 19
  year: 2015
  end-page: 31
  article-title: Fibroblast growth factor 21 protects the heart from oxidative stress
  publication-title: Cardiovasc Res
– volume: 18:
  start-page: 307
  year: 2013
  end-page: 309
  article-title: FGF21 mimetic shows therapeutic promise
  publication-title: Cell Metab
– volume: 23:
  start-page: 344
  year: 2016
  end-page: 349
  article-title: FGF21 regulates sweet and alcohol preference
  publication-title: Cell Metab
– volume: 33:
  start-page: 851
  year: 2015
  end-page: 858
  article-title: Myostatin and insulin‐like growth factor‐1 in hypertensive heart disease: a prospective study in human heart donors
  publication-title: J Hypertens
– volume: 37:
  start-page: 1286
  year: 2013
  end-page: 1294
  article-title: Activation of cardiac fibroblasts by ethanol is blocked by TGF‐β inhibition
  publication-title: Alcohol Clin Exp Res
– volume: 117:
  start-page: 568
  year: 2007
  end-page: 575
  article-title: ECM remodeling in hypertensive heart disease
  publication-title: J Clin Invest
– volume: 59:
  start-page: 30
  year: 2013
  end-page: 40
  article-title: Chronic ethanol consumption increases cardiomyocyte fatty acid uptake and decreases ventricular contractile function in C57BL/6J mice
  publication-title: J Mol Cell Cardiol
– volume: 10:
  year: 2015
  article-title: Serum level of fibroblast growth factor 21 is independently associated with acute myocardial infarction
  publication-title: PLoS One
– volume: 123:
  start-page: 327
  year: 2011
  end-page: 334
  article-title: The progression of hypertensive heart disease
  publication-title: Circulation
– volume: 25:
  start-page: 1045
  year: 2017
  end-page: 1053
  article-title: FGF21 is a sugar‐induced hormone associated with sweet intake and preference in humans
  publication-title: Cell Metab
– volume: 260:
  start-page: 163
  year: 2018
  end-page: 170
  article-title: Autophagic control of cardiac steatosis through FGF21 in obesity‐associated cardiomyopathy
  publication-title: Int J Cardiol
– volume: 104:
  start-page: 1987
  year: 2018
  end-page: 1988
  article-title: Heartbeat: the worldwide burden of atrial fibrillation
  publication-title: Heart
– volume: 6:
  year: 2016
  article-title: Fibroblast growth factor 21 deficiency exacerbates chronic alcohol‐induced hepatic steatosis and injury
  publication-title: Sci Rep
– volume: 248:
  start-page: 30
  year: 2019
  end-page: 40
  article-title: Fibroblast growth factor‐21 protects against fibrosis in hypertensive heart disease
  publication-title: J Pathol
– volume: 217:
  start-page: 287
  year: 2016
  end-page: 299
  article-title: Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre‐diabetic rats
  publication-title: Acta Physiol (Oxf)
– volume: 12:
  start-page: 572
  year: 2020
  article-title: The effects of ethanol on the heart: alcoholic cardiomyopathy
  publication-title: Nutrients
– volume: 14:
  start-page: 32
  year: 2015
  article-title: Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
  publication-title: Cardiovasc Diabetol
– volume: 11:
  start-page: 884
  year: 2010
  end-page: 892
  article-title: Alcoholic cardiomyopathy
  publication-title: J Cardiovasc Med (Hagerstown)
– volume: 60:
  start-page: 977
  year: 2014
  end-page: 989
  article-title: Fibroblast growth factor 21 protects against acetaminophen‐induced hepatotoxicity by potentiating peroxisome proliferator‐activated receptor coactivator protein‐1α‐mediated antioxidant capacity in mice
  publication-title: Hepatology
– volume: 3:
  start-page: 78
  year: 2015
  end-page: 86
  article-title: Natural history and prognostic factors in alcoholic cardiomyopathy
  publication-title: JACC Heart Fail
– volume: 1687:
  start-page: 76
  year: 2005
  end-page: 83
  article-title: Atorvastatin improves peroxisome proliferator‐activated receptor signaling in cardiac hypertrophy by preventing nuclear factor‐κB activation
  publication-title: Biochim Biophys Acta
– volume: 6:
  start-page: 1395
  year: 2017
  end-page: 1406
  article-title: Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
  publication-title: Mol Metab
– volume: 4:
  year: 2013
  article-title: Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
  publication-title: Nat Commun
– volume: 2:
  start-page: 1022
  year: 2014
  article-title: Alcoholic cardiomyopathy: multigenic changes underlie cardiovascular dysfunction
  publication-title: J Cardiol Clin Res
– volume: 139:
  start-page: 212
  year: 2018
  end-page: 218
  article-title: Serum FGF21 is associated with future cardiovascular events in patients with coronary artery disease
  publication-title: Cardiology
– volume: 49:
  start-page: 1238
  year: 2010
  end-page: 1253
  article-title: Cardiac overexpression of insulin‐like growth factor 1 attenuates chronic alcohol intake‐induced myocardial contractile dysfunction but not hypertrophy: roles of Akt, mTOR, GSK3β, and PTEN
  publication-title: Free Radic Biol Med
– volume: 11:
  start-page: 96
  year: 2018
  end-page: 103
  article-title: FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest
  publication-title: Mol Metab
– ident: e_1_2_7_4_1
  doi: 10.2459/JCM.0b013e32833833a3
– ident: e_1_2_7_17_1
  doi: 10.1371/journal.pone.0129791
– ident: e_1_2_7_6_1
  doi: 10.1136/heartjnl-2017-312384
– ident: e_1_2_7_31_1
  doi: 10.1016/j.ijcard.2018.02.109
– ident: e_1_2_7_34_1
  doi: 10.1016/j.yjmcc.2010.03.017
– ident: e_1_2_7_41_1
  doi: 10.1016/j.cmet.2013.08.014
– ident: e_1_2_7_13_1
  doi: 10.3389/fendo.2015.00133
– ident: e_1_2_7_37_1
  doi: 10.3389/fendo.2014.00107
– ident: e_1_2_7_40_1
  doi: 10.3390/nu12020572
– ident: e_1_2_7_11_1
  doi: 10.1038/ncomms3019
– ident: e_1_2_7_21_1
  doi: 10.1016/j.cmet.2015.12.008
– ident: e_1_2_7_33_1
  doi: 10.1002/hep.27060
– ident: e_1_2_7_25_1
  doi: 10.1016/j.yjmcc.2008.02.276
– ident: e_1_2_7_39_1
  doi: 10.1016/j.cmet.2014.02.004
– ident: e_1_2_7_28_1
  doi: 10.1172/JCI31044
– ident: e_1_2_7_16_1
  doi: 10.1042/CS20170271
– ident: e_1_2_7_3_1
  doi: 10.1378/chest.121.5.1638
– ident: e_1_2_7_38_1
  doi: 10.1212/WNL.0000000000003374
– ident: e_1_2_7_12_1
  doi: 10.1093/cvr/cvu263
– ident: e_1_2_7_26_1
  doi: 10.1016/j.bbalip.2004.11.004
– ident: e_1_2_7_29_1
  doi: 10.1111/acer.12111
– ident: e_1_2_7_14_1
  doi: 10.1002/path.5226
– ident: e_1_2_7_30_1
  doi: 10.1016/j.yjmcc.2013.02.005
– ident: e_1_2_7_27_1
  doi: 10.1161/CIRCULATIONAHA.108.845792
– ident: e_1_2_7_2_1
  doi: 10.1016/j.jchf.2014.07.014
– ident: e_1_2_7_19_1
  doi: 10.1016/j.molmet.2018.03.010
– ident: e_1_2_7_23_1
  doi: 10.1016/j.cmet.2017.04.009
– ident: e_1_2_7_18_1
  doi: 10.1186/s12933-015-0190-7
– ident: e_1_2_7_8_1
  doi: 10.3390/ijms17101651
– ident: e_1_2_7_5_1
  doi: 10.1016/0002-8703(93)90175-9
– ident: e_1_2_7_24_1
  doi: 10.1097/HJH.0000000000000493
– ident: e_1_2_7_9_1
  doi: 10.1152/ajpheart.00214.2016
– ident: e_1_2_7_10_1
  doi: 10.1016/j.freeradbiomed.2010.07.020
– ident: e_1_2_7_32_1
  doi: 10.1016/j.molmet.2017.08.004
– ident: e_1_2_7_15_1
  doi: 10.1159/000486127
– ident: e_1_2_7_20_1
  doi: 10.1038/srep31026
– ident: e_1_2_7_22_1
  doi: 10.1073/pnas.1611243113
– ident: e_1_2_7_7_1
  doi: 10.1136/heartjnl-2018-314443
– ident: e_1_2_7_36_1
  doi: 10.1111/apha.12698
– volume: 2
  start-page: 1022
  year: 2014
  ident: e_1_2_7_35_1
  article-title: Alcoholic cardiomyopathy: multigenic changes underlie cardiovascular dysfunction
  publication-title: J Cardiol Clin Res
– reference: 33630303 - J Pathol. 2021 Jul;254(3):213-215
SSID ssj0009955
Score 2.457046
Snippet Alcoholic cardiomyopathy (ACM) resulting from chronic alcohol misuse is one of the main contributors leading to heart failure and cardiovascular mortality....
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 198
SubjectTerms alcohol
Alcohol use
alcoholic cardiomyopathy
Animals
Cardiomegaly - pathology
Cardiomyopathy
Cardiomyopathy, Alcoholic - complications
Cardiomyopathy, Alcoholic - drug therapy
Cardiomyopathy, Alcoholic - pathology
Cardiovascular diseases
Congestive heart failure
FGF21
Fibroblast growth factors
Fibroblast Growth Factors - genetics
Fibroblast Growth Factors - metabolism
Fibroblasts
Fibrosis
Growth factors
heart
Heart Failure - etiology
Heart Failure - pathology
Humans
Hypertrophy
Klotho protein
Male
Mice
Mitochondria
Mitochondria - pathology
Myocardium
Myocytes
Myocytes, Cardiac - pathology
Oxidative Stress
Plasma levels
Protective Agents - therapeutic use
Title The protective effect of fibroblast growth factor‐21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.5573
https://www.ncbi.nlm.nih.gov/pubmed/33125701
https://www.proquest.com/docview/2477814803
https://www.proquest.com/docview/2456410794
Volume 253
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhAXaMtr26UyiAOXbDeOHzGcKkS1QiqqqlbqoVLkV9pVaYLa7GE5ceuV38gvYSZOUhWKhLglyiS2k5nxN_H4G0LemOBLHXIB3o_rBLfNJhDZZglSUAbpBMtz3Ci8_1nOjvmnE3GyQt73e2EiP8Twww0to_XXaODGXu_ckoZixd6JEAqZPjFXCwHR4S11lNZCDEzhPFU9q9CU7Qx33p2L_gCYd_FqO-HsPSanfVdjnsnFZNHYifv2G4vjf45ljTzqgCjdjZqzTlZCtUEe7HdL7U_IDSgQ7VgcwCPSmPhB65KW0FRtAXU39AyC-OacxqI9P7__YCmdV9TEsrtzR12b7Xq5rLHp5TtqKGYzokz_5OosChlHL8G5gDOuPNoExQkXleYpOd77ePRhlnRVGxKXAXZMVGZ9KJHXjEtbQsSppfVKGglYQ4FeMGOsgihHp85xYYKVXllpU-lcWk49z56R1aquwgtCPYfT3KqUOc-Z8UaWmhnOuJ_aoKUbkbf99ytcR2mOlTW-FJGMmRU4ugJf7Ii8HkS_Rh6P-4TGvRIUnSlfF4wrpAXLp3D51XAZjBBXVkwV6gXKCMkhkNZ8RJ5H5RlaybIUKwWm0NlWBf7efHGwezTDg81_F90iDxlm2bR55GOy2lwtwkuASY3dbu3hF4JREeY
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEX3o-FAgZx4JLtxrGdGHGpENUC3QqhrdQLivxKqaAJguyhnLhx5TfyS5iJk1TlISFuiTzJ2MnMeMYefwPwyARf6VBItH5CJ3RsNsHINksIgjIoJ3lR0EHhxa6a74mX-3J_DZ4OZ2EiPsS44Eaa0dlrUnBakN48QQ2lkr1TKfPsDJylit5dQPXmBDxKaylHrHCR5gOu0Ixvjo-eno1-czFPe6zdlLN9Cd4OnY2ZJu-nq9ZO3ZdfcBz_dzSX4WLvi7KtKDxXYC3UV-Hcot9tvwbfUIZYD-SARpHF3A_WVKxCXo1Fx7tlBxjHt-9YrNvz4-t3nrLDmplYeffQMdclvB4dN8T6-AkzjBIaiWZ4c30QiYxjR2hf0B7XntSC0ZxLcnMd9rafL5_Nk75wQ-IydB-TPLM-VARtJpStMOjUyvpcGYXuRo6iwY2xOQY6OnVOSBOs8rlVNlXOpdXMi-wGrNdNHW4B8wJvC5un3HnBjTeq0twILvzMBq3cBB4PP7B0Pao5Fdf4UEY8Zl7S6Er6sBN4OJJ-jFAefyLaGKSg7LX5c8lFTshgxQybH4zNqIe0uWLq0KyIRiqBsbQWE7gZpWfkkmUpFQtMsbOdDPydffl6azmni9v_Tnofzs-Xi51y58XuqztwgVPSTZdWvgHr7adVuIteU2vvdcrxE35lFgE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwELZKkSou7JQHBQziwCWvieMlhlNFeXosrSrUSj0gRd5SKtqkKnmHcuLGld_IL2EmTlKVRULcEmUS28k345l4_A0hT03wlQ6FAOvHdYLbZhOIbPMEKSiDdIIVBW4U3tqW8z3-Zl_sL5EXw16YyA8x_nBDzejsNSr4ia_Wz0lDsWLvVAiVXyKXuUwLhPTm-3PuKK2FGKnCeaYGWqGUrY-3XpyMfvMwLzqs3Ywzu0Y-DH2NiSafpovWTt2XX2gc_3Mw18nV3hOlGxE6N8hSqG-Sla1-rf0W-QYIoj2NA5hEGjM_aFPRCppqLLjdLT2AKL79SGPVnh9fv7OMHtbUxLq7h466Lt31-KzBps-eU0MxnRFlhifXB1HIOHoM1gWsce1RKSjOuIia22Rv9mr35TzpyzYkLgfnMVG59aFCYjMubQUhp5bWK2kkOBsKgMGMsQrCHJ05x4UJVnplpc2kc1mVep7fIct1U4e7hHoOp4VVGXOeM-ONrDQznHGf2qClm5Bnw_crXc9pjqU1jsrIxsxKHF2JL3ZCnoyiJ5HI409CawMIyl6XP5eMK-QFK1K4_Hi8DFqISyumDs0CZYTkEElrPiGrETxjK3meYanADDrbQeDvzZc7G7tzPLj376KPyMrO5qx893r77X1yhWHGTZdTvkaW29NFeAAuU2sfdqrxE1eoFLk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+protective+effect+of+fibroblast+growth+factor%E2%80%9021+in+alcoholic+cardiomyopathy%3A+a+role+in+protecting+cardiac+mitochondrial+function&rft.jtitle=The+Journal+of+pathology&rft.au=Gemma+Ferrer%E2%80%90Curriu&rft.au=Mariona+Guitart%E2%80%90Mampel&rft.au=Rup%C3%A9rez%2C+Celia&rft.au=Zamora%2C+Monica&rft.date=2021-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0022-3417&rft.eissn=1096-9896&rft.volume=253&rft.issue=2&rft.spage=198&rft.epage=208&rft_id=info:doi/10.1002%2Fpath.5573&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon